ATC code B06

(Redirected from ATC code B06A)

ATC code B06 Other hematological agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup B06 is part of the anatomical group B Blood and blood forming organs.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB06.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B06A Other hematological agents

edit
B06AA02 Fibrinolysin and desoxyribonuclease
B06AA03 Hyaluronidase
B06AA04 Chymotrypsin
B06AA07 Trypsin
B06AA10 Desoxyribonuclease
B06AA55 Streptokinase, combinations

B06AB Heme products

edit
B06AB01 Hemin

B06AC Drugs used in hereditary angioedema

edit
B06AC01 C1-inhibitor, plasma derived
B06AC02 Icatibant
B06AC03 Ecallantide
B06AC04 Conestat alfa
B06AC05 Lanadelumab
B06AC06 Berotralstat

B06AX Other hematological agents

edit
B06AX01 Crizanlizumab
B06AX02 Betibeglogene autotemcel
B06AX03 Voxelotor
B06AX04 Mitapivat
B06AX05 Exagamglogene autotemcel

References

edit
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code B06". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QB06". WHO Collaborating Centre for Drug Statistics Methodology.